Synergistic Endometrial Ablation System
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates radio frequency-based endometrial ablation technology with advanced technologies such as machine learning, blockchain, IoT, and nanomaterials to create a more efficient, personalized, and secure system for treating menorrhagia.
Background and Problem Solved
The original patent disclosed a radio frequency-based endometrial ablation system for treating menorrhagia. However, the system had limitations in terms of optimizing treatment parameters, securing patient data, and enhancing tissue detection. The present inventive concept addresses these limitations by incorporating synergistic combinations of distinct technologies to create a more advanced and effective system.
Detailed Description of the Inventive Concept
The synergistic endometrial ablation system comprises a radio frequency-based ablation device, a machine learning module for predicting optimal ablation parameters based on patient-specific data, a blockchain-based data management system for securing and sharing patient data and treatment outcomes, an IoT-enabled sensor array for real-time monitoring of treatment parameters, and nanomaterial-enhanced tissue sensing for enhanced tissue detection. The AI-driven simulation platform generates customized treatment plans based on patient-specific anatomy and physiology. The system enables real-time monitoring, personalized treatment planning, and secure data management, thereby improving treatment outcomes and patient satisfaction.
Novelty and Inventive Step
The novel and non-obvious aspects of the present inventive concept lie in the integration of advanced technologies with radio frequency-based endometrial ablation technology to create a more efficient, personalized, and secure system. The combination of machine learning, blockchain, IoT, and nanomaterials with radio frequency ablation technology is unprecedented and provides a significant improvement over the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the synergistic endometrial ablation system may include variations in the type of advanced technologies used, such as using different machine learning algorithms or incorporating other sensing modalities. Additionally, the system may be adapted for use in other medical applications, such as cancer treatment or cosmetic procedures.
Potential Commercial Applications and Market
The synergistic endometrial ablation system has significant commercial potential in the medical device industry, particularly in the women's health segment. The system's ability to provide personalized treatment plans, real-time monitoring, and secure data management makes it an attractive solution for healthcare providers and patients. The market for endometrial ablation devices is growing, and the present inventive concept is poised to capture a significant share of this market.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1485 |
| A | A61 | A61B5/1076 |
| A | A61 | A61B18/042 |
| A | A61 | A61B2018/0022 |
| A | A61 | A61B2018/00214 |
| A | A61 | A61B2018/00559 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00666 |
| A | A61 | A61B2018/147 |
| A | A61 | A61B2090/064 |
| A | A61 | A61B2218/008 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for minimally invasive surgical interventions, specifically electrosurgical systems for endometrial ablation, encompassing radiofrequency energy delivery, medical sensing technologies, and advanced medical informatics
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in electrosurgical technologies, advanced sensing systems, data analytics, and medical device integration, holding advanced degrees in bioengineering or medical technology with 5-10 years of practical experience
Obviousness Rationale
A PHOSITA would recognize that integrating advanced digital technologies like machine learning, IoT, and blockchain with existing radiofrequency ablation systems represents a predictable technological evolution. The source patent's foundational radiofrequency ablation methodology provides a clear technical framework for incorporating emerging digital health technologies. The proposed variations represent logical extensions of existing medical device innovation strategies focused on personalization, data security, and enhanced treatment precision.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,248 |
|---|---|
| Title | Methods and systems for endometrial ablation utilizing radio frequency |
| Assignee(s) | MINERVA SURGICAL, INC. |